Astrotech Corporation (NASDAQ:ASTC – Get Free Report) was the recipient of a large increase in short interest in May. As of May 29th, there was short interest totaling 1,007,150 shares, an increase of 2,336.3% from the May 14th total of 41,339 shares. Based on an average daily volume of 24,372,121 shares, the short-interest ratio is presently 0.0 days. Currently, 67.3% of the shares of the stock are sold short.
Hedge Funds Weigh In On Astrotech
Several large investors have recently bought and sold shares of ASTC. Susquehanna International Group LLP purchased a new position in Astrotech in the third quarter valued at $66,000. DRW Securities LLC increased its holdings in Astrotech by 168.5% in the fourth quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock valued at $109,000 after buying an additional 19,747 shares during the last quarter. Finally, J. Safra Sarasin Holding AG purchased a new position in Astrotech in the first quarter valued at $140,000. Hedge funds and other institutional investors own 24.35% of the company’s stock.
Astrotech Stock Down 6.2%
Shares of NASDAQ ASTC opened at $24.00 on Thursday. The firm has a market cap of $43.20 million, a price-to-earnings ratio of -2.85 and a beta of 4.60. Astrotech has a 52-week low of $1.91 and a 52-week high of $68.85. The business’s 50 day moving average is $9.76 and its two-hundred day moving average is $5.51.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, May 27th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.
Read Our Latest Report on Astrotech
About Astrotech
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
Read More
- Five stocks we like better than Astrotech
- The “Duck Stock” Keeps Quietly Making Money for Shareholders
- As Shares Fall, Analyst Are Boosting their Broadcom Price Targets
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
